234 related articles for article (PubMed ID: 29572286)
21. A nationwide cohort study comparing the effectiveness of diuretics and calcium channel blockers on top of renin-angiotensin system inhibitors on chronic kidney disease progression and mortality.
Faucon AL; Fu EL; Stengel B; Mazhar F; Evans M; Carrero JJ
Kidney Int; 2023 Sep; 104(3):542-551. PubMed ID: 37330214
[TBL] [Abstract][Full Text] [Related]
22. Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Barzilay JI; Davis BR; Cutler JA; Pressel SL; Whelton PK; Basile J; Margolis KL; Ong ST; Sadler LS; Summerson J;
Arch Intern Med; 2006 Nov; 166(20):2191-201. PubMed ID: 17101936
[TBL] [Abstract][Full Text] [Related]
23. 50 years of thiazides: should thiazide diuretics be considered third-line hypertension treatment?
Brown A; Captain B
Am J Ther; 2011 Nov; 18(6):e244-54. PubMed ID: 21436766
[TBL] [Abstract][Full Text] [Related]
24. Thiazide and loop diuretics.
Sica DA; Carter B; Cushman W; Hamm L
J Clin Hypertens (Greenwich); 2011 Sep; 13(9):639-43. PubMed ID: 21896142
[TBL] [Abstract][Full Text] [Related]
25. Calcium channel blockers versus other classes of drugs for hypertension.
Zhu J; Chen N; Zhou M; Guo J; Zhu C; Zhou J; Ma M; He L
Cochrane Database Syst Rev; 2022 Jan; 1(1):CD003654. PubMed ID: 35000192
[TBL] [Abstract][Full Text] [Related]
26. Calcium channel blockers versus other classes of drugs for hypertension.
Zhu J; Chen N; Zhou M; Guo J; Zhu C; Zhou J; Ma M; He L
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD003654. PubMed ID: 34657281
[TBL] [Abstract][Full Text] [Related]
27. Fixed-Dose Combinations of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in the Treatment of Hypertension: A Comparison of Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors.
Hsiao FC; Tung YC; Chou SH; Wu LS; Lin CP; Wang CL; Lin YS; Chang CJ; Chu PH
Medicine (Baltimore); 2015 Dec; 94(51):e2355. PubMed ID: 26705234
[TBL] [Abstract][Full Text] [Related]
28. Antihypertensive Medication Use in Older Patients Transitioning from Chronic Kidney Disease to End-Stage Renal Disease on Dialysis.
Chang TI; Zheng Y; Montez-Rath ME; Winkelmayer WC
Clin J Am Soc Nephrol; 2016 Aug; 11(8):1401-1412. PubMed ID: 27354656
[TBL] [Abstract][Full Text] [Related]
29. Antihypertensive Use and the Risk of Cataract in Patients with Hypertension: A Nationwide Case-control Study.
Yang HL; Byun SJ; Park S; Lee SH; Park SJ; Jung SY
Ophthalmic Epidemiol; 2023 Oct; 30(5):499-508. PubMed ID: 36369827
[TBL] [Abstract][Full Text] [Related]
30. Treatment strategies for isolated systolic hypertension in elderly patients.
Angeli F; Verdecchia P; Masnaghetti S; Vaudo G; Reboldi G
Expert Opin Pharmacother; 2020 Oct; 21(14):1713-1723. PubMed ID: 32584617
[TBL] [Abstract][Full Text] [Related]
31. Comparative estimation of the effects of antihypertensive medications on schizophrenia occurrence: a multinational observational cohort study.
Lee DY; Kim C; Kim J; Yun J; Lee Y; Chui CSL; Son SJ; Park RW; You SC
BMC Psychiatry; 2024 Feb; 24(1):128. PubMed ID: 38365637
[TBL] [Abstract][Full Text] [Related]
32. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.
Psaty BM; Lumley T; Furberg CD; Schellenbaum G; Pahor M; Alderman MH; Weiss NS
JAMA; 2003 May; 289(19):2534-44. PubMed ID: 12759325
[TBL] [Abstract][Full Text] [Related]
33. Combination therapy for hypertension in the elderly: a sub-analysis of the Combination Therapy of Hypertension to Prevent Cardiovascular Events (COPE) Trial.
Ogihara T; Matsuzaki M; Umemoto S; Rakugi H; Matsuoka H; Shimada K; Higaki J; Ito S; Kamiya A; Suzuki H; Ohashi Y; Shimamoto K; Saruta T;
Hypertens Res; 2012 Apr; 35(4):441-8. PubMed ID: 22278623
[TBL] [Abstract][Full Text] [Related]
34. Treatment and prescribing trends of antihypertensive drugs in 2.7 million UK primary care patients over 31 years: a population-based cohort study.
Rouette J; McDonald EG; Schuster T; Brophy JM; Azoulay L
BMJ Open; 2022 Jun; 12(6):e057510. PubMed ID: 35688595
[TBL] [Abstract][Full Text] [Related]
35. Goals of antihypertensive therapy.
McVeigh GE; Flack J; Grimm R
Drugs; 1995 Feb; 49(2):161-75. PubMed ID: 7729325
[TBL] [Abstract][Full Text] [Related]
36. Use of digoxin, diuretics, beta blockers, angiotensin-converting enzyme inhibitors, and calcium channel blockers in older patients in an academic hospital-based geriatrics practice.
Fishkind D; Paris BE; Aronow WS
J Am Geriatr Soc; 1997 Jul; 45(7):809-12. PubMed ID: 9215330
[TBL] [Abstract][Full Text] [Related]
37. Comparative effectiveness of angiotensin-converting enzyme inhibitors versus beta-blockers as second-line therapy for hypertension.
Magid DJ; Shetterly SM; Margolis KL; Tavel HM; O'Connor PJ; Selby JV; Ho PM
Circ Cardiovasc Qual Outcomes; 2010 Sep; 3(5):453-8. PubMed ID: 20716714
[TBL] [Abstract][Full Text] [Related]
38. Combination antihypertensive therapy among patients with COPD.
Herrin MA; Feemster LC; Crothers K; Uman JE; Bryson CL; Au DH
Chest; 2013 May; 143(5):1312-1320. PubMed ID: 23287970
[TBL] [Abstract][Full Text] [Related]
39. The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker.
Kuti EL; Baker WL; White CM
Curr Med Res Opin; 2007 Jun; 23(6):1239-44. PubMed ID: 17559720
[TBL] [Abstract][Full Text] [Related]
40. Use of Antihypertensive Agents and Association With Risk of Adverse Outcomes in Chronic Kidney Disease: Focus on Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers.
Ku E; McCulloch CE; Vittinghoff E; Lin F; Johansen KL
J Am Heart Assoc; 2018 Oct; 7(19):e009992. PubMed ID: 30371331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
